Vimarsana
Biggest News Aggregation in the World

Page 33 - Adv News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adv Today - Breaking & Trending Today

New major survey presented at the EADV Congress finds 'healthy' suntan myths persist despite warnings about skin cancer and aging - Vimarsana News

New major survey presented at the EADV Congress finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

8 in 10 Europeans believe tans are attractive with almost as many (73%) saying tans are healthy, according to a new study presented today at the 31st European Academy of Dermatology and Venereology

Ramaphosa appoints anti-corruption advisory council members - Vimarsana News

Ramaphosa appoints anti-corruption advisory council members

President Cyril Ramaphosa has appointed a nine-member anti-corruption advisory council to strengthen his administration’s fight against graft.

Data from Incyte's Dermatology Portfolio Accepted for Presentation at the 2022 European Academy of Dermatology and Venereology (EADV) Congress - Vimarsana News

Data from Incyte's Dermatology Portfolio Accepted for Presentation at the 2022 European Academy of Dermatology and Venereology (EADV) Congress

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV)

Dermavant Sciences: Dermavant to Present New Data from Phase 3 Trial Program of VTAMA (tapinarof) cream, 1% for Adults with Plaque Psoriasis at the 2022 EADV Congress - Vimarsana News

Dermavant Sciences: Dermavant to Present New Data from Phase 3 Trial Program of VTAMA (tapinarof) cream, 1% for Adults with Plaque Psoriasis at the 2022 EADV Congress

- Two posters will highlight clinical data for VTAMA cream on treat-to-target outcomes and quality of life measures - Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing

17-year jail term for men who killed 92–year-old relative they accused of witchcraft - Vimarsana News

17-year jail term for men who killed 92–year-old relative they accused of witchcraft

The Eastern Cape High Court, sitting in Sterkspruit, has sentenced four men convicted of killing a 92-year-old woman they accused of practising witchcraft to an effective 17 years behind bars.